Pay in 4 interest-free payments of $46.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
permitting ETF1/ERF1 to accommodate fully in the A-site
25(6): 317-322
RSPO1 stands out among RSPOs molecules with respect to its potential therapeutic use
a protein modifier
the nucleoprotein could be responsible for inhibiting T-cell activation during infection by HRSV
Human E2F1 ELISA Kit Biosimilar Antibody permitting ETF1/ERF1 to accommodate fullyProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and
US$ 93.00
US$ 28.80
US$ 125.35
US$ 11.30